The Synergistic Effects of Home-management and Intermittent Preventive Treatment of Malaria in Children

PHASE4CompletedINTERVENTIONAL
Enrollment

1,490

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

October 31, 2008

Conditions
Malaria
Interventions
DRUG

Amodiaquine plus Artesunate co-administration

"Under the Home Management of Malaria (HMM) strategy the Community Drug Distributors (CDD) will treat all children under 5 years presented to them with measured fever or a history of fever with AQ plus AS co-administered. Children under 12 months receive 75mg of AQ co-administered with 25mg of AS daily for three days. Children who are 12 to 59 months old receive 150mg of AQ and 50mg of AS co-administered daily for three days.~Asymptomatic children under 5 years in the Intermittent Preventive Treatment (IPTc) clusters will receive additional AQ plus AS co-administered during high malaria transmission season. Those under 12 months will receive 75mg of AQ co-administered with 25mg of AS daily for three days; and children who are 12 to 59 months old receive 150mg of AQ and 50mg of AS co-administered daily for three days."

Trial Locations (1)

Unknown

District Health Administration, Ejisu

All Listed Sponsors
collaborator

Department for International Development, United Kingdom

OTHER_GOV

collaborator

Malaria Consortium, UK

NETWORK

collaborator

Center for International Health and Development

OTHER

lead

Kwame Nkrumah University of Science and Technology

OTHER

NCT00550160 - The Synergistic Effects of Home-management and Intermittent Preventive Treatment of Malaria in Children | Biotech Hunter | Biotech Hunter